Nanoparticle-Conjugated TLR9 Agonists Improve the Potency, Durability, and Breadth of COVID-19 Vaccines https://www.biorxiv.org/content/10.1101/2023.01.02.522505v1?med=mas
Nanoparticle-Conjugated TLR9 Agonists Improve the Potency, Durability, and Breadth of COVID-19 Vaccines https://www.biorxiv.org/content/10.1101/2023.01.02.522505v1?med=mas